Korean J Dermatol.  2008 Oct;46(10):1398-1401.

A Case of Lymphangioma Treated by OK-432 (Picibanil(R)) Sclerotherapy

Affiliations
  • 1Department of Dermatology, Wonkwang University School of Medicine, Iksan, Korea. sdpark@wonkwang.ac.kr
  • 2Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea.

Abstract

Lymphangioma is an uncommon, benign hyperproliferation of the lymphatic vessels, and this consists of dilated lymphatic channels lined by a normal, single layer of endothelial cells. Various methods have been tried for the treatment of lymphangioma, including cryotherapy, electrocauterization, surgical excision, laser therapy, radiotherapy and itralesional injection of sclerosing agents. Yet these methods have shown low success rates and various side effects. It has recently been reported that intralesional injection of OK-432 is a safe and effective alternative therapy for lymphangioma, and especially for macrocystic lesion. In this report, we describe a patient with lymphangioma on the upper labial mucosa and this patient was successfully treated with intralesional injection of OK-432 without any serious complications. To the best of our knowledge, this is the first such case reported on in the Korean dermatological literature.

Keyword

Lymphangioma; OK-432

MeSH Terms

Cryotherapy
Endothelial Cells
Humans
Injections, Intralesional
Laser Therapy
Lymphangioma
Lymphatic Vessels
Mucous Membrane
Picibanil
Sclerosing Solutions
Sclerotherapy
Picibanil
Sclerosing Solutions
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr